Management of proliferative vitreoretinopathy

Abstract

Proliferative vitreoretinopathy (PVR) is a term coined by the Retina Society Terminology Committee in 1983 to describe retinal detachment caused by contractile cellular membranes on the retina and vitreous following rhegmatogenous retinal detachment (RRD) [1]. Contraction of these membranes can lead to new retinal detachments (RD) or failure of surgically corrected detachments. PVR still remains the leading cause of failure in retinal detachment surgery, occurring in 5–10 % of all RRDs, and remains a major barrier to successful repair of RDs [2].